Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Study Cohort

AV Ami Vyas
MG Meghan Gabriel
SK Sobha Kurian
ask Ask a question
Favorite

We included women aged 66 and above at the diagnosis of first pathologically confirmed metastatic BC15 during 2010–2013 with HER2-negative status. Women diagnosed via a death certificate or autopsy were excluded. Additionally, we excluded women who were enrolled in health maintenance organizations, who were not continuously enrolled in Medicare parts A and B for 12 months before cancer diagnosis through at least 6 months following diagnosis or death, and who were not continuously enrolled in Medicare part D for at least 6 months following diagnosis or death, whichever occurred first.

Copyright and License information:  ©2021 Vyas et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A